Anemia secondary to valproic acid therapy in a 13-year-old boy: a case report

Barbara Kaczorowska-Hać, Agnieszka Matheisel, Lucyna Maciejka‐Kapuścińska, Jakub Wiśniewski, Anna Alska, Elżbieta Adamkiewicz-Drożyńska, Anna Balcerska, Iwona Reszczyńska

Journal of Medical Case Reports · 2012 · 16 citations · 9 references

DOIFull text

Open access

Concepts

Abstract

INTRODUCTION: Valproic acid is a commonly used anti-epileptic drug. Hematological toxicities are among the occasionally observed adverse effects of this medication. CASE PRESENTATION: We present the case of a 13-year-old Caucasian boy who demonstrated mild anemia 12 months after the introduction of valproic acid therapy. A bone marrow biopsy revealed maturation arrest of proerythroblasts. CONCLUSION: Prompt diagnosis and valproic acid discontinuation resulted in the patient's recovery.

References

9